Rabbits possess a robust and unique immune system that generates antibodies with superior specificity, affinity and diversity compared to rodents. This makes them highly recommended for producing high-quality antibodies. In the dynamic field of pharmaceutical development, the need for high precision and rigorous safety validation is critical to ensuring the efficacy and safety of new therapeutics.
Therefore, anti-idiotypic antibodies (anti-ID Abs) play a crucial role in this process by binding to therapeutic drugs in biological fluids, facilitating drug validation and safety evaluation. They are commonly used in pharmacokinetics (PK) and pharmacodynamics (PD) assays to assess drug efficacy and are instrumental in evaluating drug safety through anti-drug antibody (ADA) assays, which measure immunogenicity.
In this webinar, the expert speaker will provide a detailed overview of anti-ID abs, exploring their significance and applications. She will also delve into the reasons why rabbits are the preferred host for generating high-performance anti-ID abs and highlight the advantages that make them ideal for this purpose. Additionally, attendees will gain insights into the advanced techniques and methodologies to optimize the development of these crucial antibodies, enhancing therapeutic and diagnostic outcomes in the biopharmaceutical industry.
Register for this webinar today to discover why rabbits are the preferred choice for generating high-performance anti-ID Abs and learn advanced techniques to optimize antibody development.
Speaker
Dr. Hui Foon Tan, PhD, Sr. Global Product Manager - Antibody, GenScript Biotech
Dr. Hui Foon Tan is a Global Product Manager who supports GenScript antibody production service currently. She graduated with her PhD in Biological Sciences from Nanyang Technological University, Singapore, and continued to work as a Postdoctoral Research Fellow in Cancer Research for another two years.
After she joined GenScript, Dr. Tan has supported the proteins and antibody production services in APAC region for a year. She provides application support for pre- and post-sale activities for services as well as updates and seminars to support co-stakeholders, distributors and customers.
Currently, she is supporting new service launches and training in antibody production services. She also collates market dynamics and competitive market information from the field to understand the global market trends and collaborate with the team.
Message PresenterWho Should Attend?
This webinar will appeal to Researchers and Scientists working in the following areas or professionals working in the biotech and pharmaceutical industry:
- Antibody drug development and gene/cell therapy
- Antibody discovery and engineering
- Gene and cell therapy
- PK/ADA assay
- Biomedical/Clinical Trial Researchers
What You Will Learn
Attendees will learn about:
- The relevance of anti-ID Abs in antibody development
- Why rabbits are the preferred host for generating high-performance anti-ID Abs
- The discovery strategies and capabilities for developing rabbit anti-ID Abs
Xtalks Partner
GenScript
GenScript is the leading contract research organization in the world providing gene, peptide, protein, CRISPR, and antibody. Since its foundation in 2002, GenScript has grown exponentially through partnerships with scientists conducting fundamental life science research, translational biomedical research, and early stage pharmaceutical development. The company is recognized as having built a best-in-class capacity and capability for biological research services, encompassing gene synthesis, peptide synthesis, custom antibody and protein engineering, and in vitro and in vivo pharmacology – all with the goal to Make Research Easy.
Related Webinars
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account